Charles Schwab Investment Management Inc. Acquires 65,152 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Charles Schwab Investment Management Inc. boosted its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 6.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,064,224 shares of the company’s stock after buying an additional 65,152 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.89% of Privia Health Group worth $19,380,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of PRVA. Sequoia Financial Advisors LLC grew its stake in shares of Privia Health Group by 2.3% in the third quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock worth $478,000 after acquiring an additional 583 shares during the last quarter. Benjamin F. Edwards & Company Inc. grew its position in Privia Health Group by 8.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock worth $134,000 after purchasing an additional 605 shares during the last quarter. Arizona State Retirement System increased its holdings in shares of Privia Health Group by 2.4% during the 2nd quarter. Arizona State Retirement System now owns 26,574 shares of the company’s stock worth $462,000 after purchasing an additional 617 shares during the period. Signaturefd LLC raised its position in shares of Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after buying an additional 626 shares during the last quarter. Finally, Parkside Financial Bank & Trust lifted its stake in shares of Privia Health Group by 9.7% in the second quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company’s stock valued at $151,000 after buying an additional 771 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the transaction, the chief executive officer now owns 247,771 shares in the company, valued at $4,583,763.50. This represents a 35.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 14.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Truist Financial boosted their price target on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Royal Bank of Canada restated an “outperform” rating and issued a $28.00 target price on shares of Privia Health Group in a research note on Wednesday, August 14th. KeyCorp initiated coverage on shares of Privia Health Group in a research note on Friday, October 11th. They set an “overweight” rating and a $23.00 price target on the stock. Robert W. Baird boosted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Friday, November 29th. Two investment analysts have rated the stock with a hold rating, eleven have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $24.79.

Privia Health Group Trading Down 0.2 %

NASDAQ PRVA opened at $21.18 on Friday. The firm has a market cap of $2.54 billion, a price-to-earnings ratio of 212.20, a PEG ratio of 5.63 and a beta of 0.83. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $24.30. The company has a 50 day moving average of $19.54 and a 200-day moving average of $18.82.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.